sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
29-Aug-2015 03:27
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 251-275 out of 1092.

<< < 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 > >>

Public Release: 8-Apr-2015
Science Translational Medicine
Plotting the elimination of dengue
Researchers at the University of Melbourne along with international collaborators are using a novel way to block the dengue virus in Aedes aegypti mosquitoes using the insect bacterium, Wolbachia and have for the first time provided projections of its public health benefit.

Contact: Anne Rahilly
arahilly@unimelb.edu.au
61-390-355-380
University of Melbourne

Public Release: 8-Apr-2015
International Journal of Public Health
Case study Cabo Verde: Simulation offers policy Rx for curbing HIV
The African archipelago nation of Cabo Verde could bring its HIV epidemic under control within 10 years by ramping up a combination of four interventions already underway, according to projections from a sophisticated computer model led by Brown University public health researchers. Much of the progress could be achieved, the model predicts, by focusing the effort just on the most at-risk populations.
National Institutes of Health

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 8-Apr-2015
Nature
In first human study, new antibody therapy shows promise in suppressing HIV infection
In the first results to emerge from HIV patient trials of a new generation of so-called broadly neutralizing antibodies, Rockefeller University researchers have found the experimental therapy can dramatically reduce the amount of virus present in a patient's blood.
Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery, NIH/Cooperative Centers on Human Immunology, National Center for Advancing Translational Science, Robertson Foundation, NIH/National Cancer Institute

Contact: Zach Veilleux
zveilleux@rockefeller.edu
212-327-8982
Rockefeller University

Public Release: 7-Apr-2015
Journal of Allergy and Clinical Immunology
Asthma rates among black youth are similarly high in urban, rural communities
Asthma rates among black youth living in urban Detroit and rural Georgia are essentially the same, researchers report, a finding that conflicts with the widely held theory that city life is a risk factor, and pointing instead toward poverty.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 7-Apr-2015
Journal of Clinical Investigation
Gene variant and environment can boost severity of respiratory syncytial virus
A particular genetic mutation combined with an urban environment increases the risk of severe disease in children infected with respiratory syncytial virus, an international team of investigators has found.
Bill & Melinda Gates Foundation, National Institutes of Health

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center

Public Release: 7-Apr-2015
PLOS Medicine
Epidemiology of HIV-1 transmitted drug resistance
Only a limited number of surveillance drug-resistance mutations are responsible for most instances of non-nucleoside reverse transcriptase inhibitor- and nucleoside reverse transcriptase inhibitor-associated resistance, and most strains of HIV-1 transmitted drug resistance in sub-Saharan Africa and south/southeast Asia arose independently, according to a study led by Soo-Yon Rhee of Stanford University, published this week in PLOS Medicine.
National Institutes of Health, Bill & Melinda Gates Foundation, Centers for AIDS Research

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 7-Apr-2015
PLOS Medicine
Stanford-led study finds limited mutations involved in transmission of drug-resistant HIV
In the largest study of its kind to date, researchers at Stanford University School of Medicine and their colleagues have found that worldwide only a limited number of mutations are responsible for most cases of transmission of drug-resistant HIV.
National Institutes of Health, Bill & Melinda Gates Foundation, Center for AIDS Research

Contact: Ruthann Richter
richter1@stanford.edu
650-725-8047
Stanford University Medical Center

Public Release: 6-Apr-2015
Obstetrician-gynecologist training in Sub-Saharan Africa bolstered by new collections
A new project provides free access to educational materials to support obstetrician-gynecologist training in Africa and improve maternal and newborn care.
World Bank

Contact: Beata Mostafavi
bmostafa@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 6-Apr-2015
Journal of Medical Entomology
For ticks, researchers find lemur noses to be males only in Madagascar
Out of 295 ticks collected from the noses of lemurs in Madagascar, 100 percent of them were male. The chosen location may provide a convenient jump-off point for male ticks to switch hosts as the lemurs sniff each other.

Contact: Richard Levine
rlevine@entsoc.org
301-731-4535
Entomological Society of America

Public Release: 3-Apr-2015
Case Western Reserve to lead international research on resistance to bacteria causing TB
After discovering a unique group of people resistant to tuberculosis (TB) infection, Case Western Reserve researchers are leading an international team dedicated to understanding exactly how they fight off a disease that claims 1.5 million lives each year. The team's goal is to use lessons learned from these resistant individuals to develop an approach to treating and curing TB that is unlike any existing medication.
National Institutes of Health, Bill & Melinda Gates Foundation

Contact: Jeannette Spalding
jeannette.spalding@case.edu
216-368-3004
Case Western Reserve University

Public Release: 3-Apr-2015
Annals of Emergency Medicine
Doctor at Rhode Island Hospital develops Ebola virus diagnostic tool
Adam C. Levine, M.D., an emergency medicine physician at Rhode Island Hospital and The Miriam Hospital who treated Ebola-infected patients in Liberia last year, used his field experience to create a tool to determine the likelihood that patients presenting with Ebola symptoms will actually carry the virus. His research was published in the Annals of Emergency Medicine today.

Contact: Beth Bailey
bbailey@lifespan.org
401-444-6421
Lifespan

Public Release: 2-Apr-2015
New England Journal of Medicine
Deaths from cardiovascular disease increase globally while mortality rates decrease
Deaths from cardiovascular disease increase globally while mortality rates decrease.

Contact: Rhonda Stewart
stewartr@uw.edu
206-897-2863
Institute for Health Metrics and Evaluation

Public Release: 1-Apr-2015
PLOS Neglected Tropical Diseases
New class of insecticides offers safer, more targeted mosquito control
Purdue researchers have identified a new class of chemical insecticides that could provide a safer, more selective means of controlling mosquitoes that transmit key infectious diseases such as dengue, yellow fever and elephantiasis.
US Department of Defense, Purdue Research Foundation, Indiana Clinical and Translational Sciences Institute, NIH/National Center for Advancing Translational Science

Contact: Natalie van Hoose
nvanhoos@purdue.edu
765-496-2050
Purdue University

Public Release: 1-Apr-2015
Infection Control and Hospital Epidemiology
Ebola planning created need for unprecedented preparedness in hospitals
Hospitals and health systems preparing for and treating patients with Ebola virus disease in the fall of 2015 faced unexpected challenges for ensuring safety of staff, patients and the community. The experiences are detailed in two studies published online in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

Contact: Tamara Moore
tmoore@gymr.com
202-745-5114
Society for Healthcare Epidemiology of America

Public Release: 1-Apr-2015
New England Journal of Medicine
Experimental Ebola vaccine safe, prompts immune response
An early-stage clinical trial of an experimental Ebola vaccine conducted at the National Institutes of Health and the Walter Reed Army Institute of Research found that the vaccine, called VSV-ZEBOV, was safe and elicited robust antibody responses in all 40 of the healthy adults who received it.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 1-Apr-2015
New England Journal of Medicine
VSV-EBOV Ebola vaccine appears safe and generates immune response
An experimental Ebola vaccine called VSV-EBOV appears safe and elicited a robust immune response in a small phase 1 clinical trial, according to findings to be published in the New England Journal of Medicine on April 2, 2015. Two independent but coordinated studies, performed at the Walter Reed Army Institute of Research and the National Institute of Allergy and Infectious Diseases, explored the safety and immunogenicity of the investigational vaccine when administered at different dosages.
NIH/National Institute of Allergy and Infectious Diseases, NIH/National Cancer Institute,Defense Threat Reduction Agency, Joint Vaccine Acquisition Program

Contact: Dr. Debra Yourick
debra.l.yourick.civ@mail.mil
301-319-9471
US Army Medical Research Institute of Infectious Diseases

Public Release: 1-Apr-2015
Global Heart
Barriers found that prevent Ugandans with RHD from receiving needed penicillin
Access to penicillin can prevent deaths from rheumatic heart disease. Researchers from Case Western Reserve University, Makerere University and the Uganda Heart Institute at Mulago Hospital, a national referral hospital in Kampala, collaborated to learn about obstacles that prevent people from receiving the medication and find ways to overcome them.
The Arnold P. Gold Foundation

Contact: Susan Griffith
susan.griffith@case.edu
216-368-1004
Case Western Reserve University

Public Release: 1-Apr-2015
Lancet Global Health
Simpler antibiotic treatments could help millions of infants who lack access to hospitals
Giving fewer antibiotic injections to young infants in the developing world with severe infections such as pneumonia and sepsis is just as safe and effective as the standard course of twice daily injections over the course of a week, according to new Johns Hopkins School of Public Health research conducted in Bangladesh.
United States Agency for International Development, Bill & Melinda Gates Foundation

Contact: Brandon Howard
brandonhoward@jhu.edu
410-502-9059
Johns Hopkins University Bloomberg School of Public Health

Public Release: 31-Mar-2015
Journal of Public Health Management and Practice
How did he do it? Mayor Bloomberg's public health strategy evaluated in Journal of Public Health Management and Practice
How did former New York City Mayor Michael Bloomberg succeed in achieving so much of his 'comprehensive and far-reaching' public health agenda? Key strategies included harnessing the full authority of the City health department and mobilizing the existing workforce to focus on targeted reforms, according to a study in the March/April issue of the Journal of Public Health Management and Practice. The journal is published by Wolters Kluwer.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 31-Mar-2015
Nature Communications
Pig-borne disease most likely jumped into humans when rearing practices changed
The most virulent strains of Streptococcus suis, the leading cause of bacterial meningitis in adult humans in parts of southeast Asia and in pigs around the world, are likely to have evolved and become widespread in pigs at the same time as changes in rearing practices, according to research from an international consortium published today in the journal Nature Communications.
Biotechnology and Biological Sciences Research Council

Contact: Craig Brierley
craig.brierley@admin.cam.ac.uk
44-012-237-66205
University of Cambridge

Public Release: 31-Mar-2015
Proceedings of the Royal Society B
Faulty modeling studies led to overstated predictions of Ebola outbreak
Frequently used approaches to understanding and forecasting emerging epidemics -- including the West African Ebola outbreak -- can lead to big errors that mask their own presence, according to a University of Michigan ecologist and his colleagues.

Contact: Jim Erickson
ericksn@umich.edu
734-647-1842
University of Michigan

Public Release: 31-Mar-2015
Bulletin of the World Health Organization
Study -- Governments can prevent tragic death toll of mothers and babies
'Inequities in postnatal care in low- and middle-income countries: a systematic review and meta-analysis' is by Étienne V. Langlois, Malgorzata Miszkurka, Maria Victoria Zunzunegui, Abdul Ghaffar, Daniela Zieglerc & Igor Karp.

Contact: Fiona Fleck
fleckf@who.int
41-227-911-897
Bulletin of the World Health Organization

Public Release: 30-Mar-2015
Journal of Clinical Investigation
Blood-based biomarkers could enable simple, accurate TB tests for diagnosis and monitoring
Researchers have identified blood-based biomarkers in patients with active tuberculosis that could lead to new blood-based diagnostics and tools for monitoring treatment response and cure.
National Institutes of Health, Emory Center for AIDS Research, Emory Global Health Institute, Yerkes National Primate Research Center

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory Health Sciences

Public Release: 27-Mar-2015
NYU developing HIV antibodies and RNA test in a single POC
NYU College of Dentistry has received a sub-award in the amount of $335,000 from a Small Business Innovation Research (SBIR) Phase II grant from NIH to complete the development of a fully automated self-confirming assay that can simultaneously detect HIV/AIDS antibodies and viral RNA from the AIDS virus in a single specimen.
NIH/Small Business Innovation Research Phase II Grant

Contact: Christopher James
christopher.james@nyu.edu
212-998-6876
New York University

Public Release: 27-Mar-2015
Lancet
Research on medical abortion and miscarriage may change international routines
Two scientific studies led by researchers at Sweden's Karolinska Institutet are expected to form the basis of new international recommendations for the treatment of medical abortions and miscarriages. Both studies are being published in the journal 'The Lancet'.
Swedish Research Council, Karolinska Institutet, Stockholm County Council, Dalarna University, World Health Organization

Contact: KI Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet

Showing releases 251-275 out of 1092.

<< < 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 > >>